Your browser doesn't support javascript.
loading
Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor.
Fukushima, Hiroko; Yamasaki, Kai; Sakaida, Miho; Tsujio, Nozomi; Okuno, Takahiro; Ishii, Naomi; Okada, Keiko; Fujisaki, Hiroyuki; Matsusaka, Yasuhiro; Sakamoto, Hiroaki; Yoneda, Akihiro; Hara, Junichi; Inoue, Takeshi.
Afiliação
  • Fukushima H; Department of Pathology, Osaka City Juso Hospital, Osaka, Japan.
  • Yamasaki K; Department of Pathology, Osaka City General Hospital, Osaka, Japan.
  • Sakaida M; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan.
  • Tsujio N; Department of Pathology, Osaka City General Hospital, Osaka, Japan.
  • Okuno T; Department of Pathology, Osaka City General Hospital, Osaka, Japan.
  • Ishii N; Department of Pathology, Osaka City General Hospital, Osaka, Japan.
  • Okada K; Department of Pathology, Osaka City General Hospital, Osaka, Japan.
  • Fujisaki H; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan.
  • Matsusaka Y; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan.
  • Sakamoto H; Department of Pediatric Neurosurgery, Osaka City General Hospital, Osaka, Japan.
  • Yoneda A; Department of Pediatric Neurosurgery, Osaka City General Hospital, Osaka, Japan.
  • Hara J; Department of Pediatric Surgery, Osaka City General Hospital, Osaka, Japan.
  • Inoue T; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan.
Pathol Int ; 71(2): 155-160, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33378586
ABSTRACT
We report a case of rhabdoid tumor predisposition syndrome with a renal tumor developing 10 years after a brain tumor, which demonstrated an unexpectedly favorable outcome. A 2-year-old boy underwent gross total resection of a brain tumor located in the fourth ventricle, and received adjuvant chemotherapy and radiotherapy. At the age of 11 years, a renal tumor was found and nephrectomy was performed. He is currently alive without evidence of disease over 2 years without postoperative therapy. Histologically, rhabdoid cells were observed in both brain and renal tumors. Loss of SMARCB1 (also known as INI1) expression was found in the nucleus of both tumor cells. Genetic testing revealed pathogenic variants of SMARCB1 exon 5 in the renal tumor and SMARCB1 exon 9 in the brain tumor. In addition, heterozygous deletion of 22q11.21-q11.23 containing the SMARCB1 locus was shared by both tumors and this deletion was identified in normal peripheral blood. Considering the histopathological and genetic findings, our case was considered to be rhabdoid tumor predisposition syndrome with atypical teratoid/rhabdoid tumor and late-onset rhabdoid tumor of the kidney.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Tumor Rabdoide / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Child / Child, preschool / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Tumor Rabdoide / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Child / Child, preschool / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article